Delivra Health Brands Inc.
DHBUF
$0.1364
$0.00725.57%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 8.66% | 0.19% | 25.30% | 41.97% | 31.25% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 8.66% | 0.19% | 25.30% | 41.97% | 31.25% |
| Cost of Revenue | 14.86% | -2.10% | 19.40% | 4.00% | -1.08% |
| Gross Profit | 3.07% | 2.47% | 31.36% | 105.30% | 86.23% |
| SG&A Expenses | 20.69% | 19.80% | 18.06% | 11.20% | -0.86% |
| Depreciation & Amortization | -3.21% | -3.02% | -2.55% | -15.41% | -26.00% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 15.44% | 6.88% | 16.20% | 4.42% | -4.53% |
| Operating Income | -135.41% | -149.53% | 49.00% | 93.97% | 83.62% |
| Income Before Tax | 101.64% | -62.82% | 531.73% | 72.58% | 69.90% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 101.64% | -62.82% | 531.73% | 72.58% | 69.90% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 101.64% | -62.82% | 531.73% | 72.58% | 69.90% |
| EBIT | -135.41% | -149.53% | 49.00% | 93.97% | 83.62% |
| EBITDA | -133.28% | -109.83% | 1,872.55% | 164.15% | 131.12% |
| EPS Basic | 99.68% | -96.00% | 425.86% | 75.83% | 70.75% |
| Normalized Basic EPS | 26.72% | -31.00% | 51.46% | 54.90% | 51.14% |
| EPS Diluted | 97.46% | -102.33% | 235.82% | 77.20% | 72.68% |
| Normalized Diluted EPS | 29.75% | -20.10% | 56.29% | 57.28% | 51.73% |
| Average Basic Shares Outstanding | 21.05% | 17.86% | 13.11% | 7.18% | 1.24% |
| Average Diluted Shares Outstanding | 31.59% | 21.50% | 17.01% | 11.41% | -4.29% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |